Kelly McBride is the NPR Public Editor, the public's representative to NPR. She serves as an independent voice on questions raised by listeners and readers of news broadcast and published by NPR. You ...

Tensions are rising over the delays in SNAP benefits, and understandably, people are worried. But before this becomes another left-versus-right argument, maybe it’s time to ask why we’ve become so ...

Brussels' shift on privacy comes as it frets over Europe's waning economic power. Former Italian Prime Minister Mario Draghi ...

There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...